2020 Vegas Meeting Masthead

ASBrS 2020 Industry Symposia

The American Society of Breast Surgeons is pleased to offer the opportunity for Industry-Supported Symposia* at its annual meeting. Symposia are live educational programs sponsored and funded by an outside organization, independently organized and offered. Industry-supported symposia, which have been made possible through marketing support, will be offered throughout the annual meeting: Wednesday, Thursday, and Friday evening, as well as Friday and Saturday morning. Details on these programs are listed below, including how to register and who to contact for more information. This information will be updated as we receive additional programming details.

*Satellite Symposia are supported by specific companies through marketing grants. They are not part of the official program of the ASBrS and are free to all registered attendees.


Wednesday Evening Symposia

April 29, 8:00 PM–9:30 PM

Program Information to be announced when available.

Thursday Evening Symposium

April 30, 5:30 PM–7:30 PM

Exact Sciences (formally Genomic Health, Inc.)

Less is More: De-escalation of Local and Systemic Therapy with the Breast Recurrence Score® Test

For more information please contact Ann Kopischke at akopischke@exactsciences.com.


Note: This satellite symposium is supported by Exact Sciences (formally Genomic Health, Inc.) through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Friday Breakfast Symposia

May 1, 6:30 AM–7:45 AM

PeerView Institute

The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage & Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons

Program Objective:

After participating in the activity, the learners are expected to be better able to:

  1. Describe the foundational aspects of and rationale for harnessing the immune system in the treatment of triple-negative breast cancer (TNBC)
  2. Discuss efficacy, safety, biomarker, and other key data from clinical trials assessing immune checkpoint inhibitors and immunotherapy-based combinations in advanced and early-stage TNBC
  3. Integrate immunotherapies into multimodal management of patients with advanced and early-stage TNBC according to the latest evidence and best practice recommendations, and in the context of effective multidisciplinary collaboration and coordination of care

Brief Summary of Program:

This educational program will provide participating breast surgeons, breast oncologists, and other professionals involved in the care with patients with breast cancer with up-to-date information on the current and emerging role of cancer immunotherapies in triple-negative breast cancer (TNBC). Experts will evaluate the accumulating evidence from clinical trials and highlight the evolving role of immune checkpoint inhibition in metastatic and early-stage disease settings of TNBC. Practical guidance will also be provided related to the nuances of integration of immunotherapies and combinations into treatment plans for patients with TNBC throughout the disease continuum, and how to maximize the potential of these agents in the context of multimodal therapy and multidisciplinary patient care.

To register, please visit PeerView.com/TNBCLV20. For additional information about the program, contact PeerView at 1.877.833.6141 or live@PeerView.com.

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. This activity is supported by an independent educational grant from Merck & Co., Inc.


Note: This satellite symposium is supported by Merck & Co., Inc., through an independent educational grant provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. CME credits for this program will be provided by Medical Learning Institute, Inc. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Friday Evening Symposia

May 1, 7:30 PM–9:30 PM

Agendia, Inc.

Comprehensive Profiling of Early-Stage Breast Cancer: A More Effective Path to Treatment Planning

Program Objective:

To educate the audience on ways genomic profiling may facilitate a faster, clearer and more effective path to care for women with early stage breast cancer.

Brief Summary of Program:

Physicians face many challenges when trying to formulate both pre- and post-operative treatment plans. This session will explore time to treatment and how the implementation of comprehensive decision support tools can reliably support medical management decisions to improve patient outcomes.

For additional information about the program and how to register, please contact Dina Scaglione at dina.scaglione@agendia.com.


Note: This satellite symposium is supported by Agendia through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Stryker

For additional information about the program and how to register, please contact Kimmy Sullivan at kimmy.sullivan@stryker.com.


Note: This satellite symposium is supported by Stryker through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Saturday Breakfast Symposia

May 2, 6:30 AM–7:45 AM

Hologic

For additional information about the program and how to register, please contact Jennifer Cotting at Jennifer.Cotting@Hologic.com.


Note: This satellite symposium is supported by Hologic through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Other Special Events

Our Special Events page has even more Annual Meeting events held throughout the General Session.